A. Martoni

430 total citations
23 papers, 153 citations indexed

About

A. Martoni is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, A. Martoni has authored 23 papers receiving a total of 153 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in A. Martoni's work include Cancer Treatment and Pharmacology (14 papers), Colorectal Cancer Treatments and Studies (6 papers) and Breast Cancer Treatment Studies (4 papers). A. Martoni is often cited by papers focused on Cancer Treatment and Pharmacology (14 papers), Colorectal Cancer Treatments and Studies (6 papers) and Breast Cancer Treatment Studies (4 papers). A. Martoni collaborates with scholars based in Italy. A. Martoni's co-authors include F Pannuti, Elena Strocchi, C. Zamagni, C. M. Camaggi, Barbara Melotti, M. Guaraldi, A. Paccagnella, Fiorenza Fruet, Luigi Dogliotti and Filippo de Marinis and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Cancer and Lung Cancer.

In The Last Decade

A. Martoni

23 papers receiving 145 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Martoni Italy 7 101 67 38 26 19 23 153
G Moro Italy 7 112 1.1× 45 0.7× 69 1.8× 62 2.4× 7 0.4× 16 196
Donatella Grasso Italy 9 107 1.1× 40 0.6× 26 0.7× 25 1.0× 13 0.7× 22 159
Robert McCroskey United States 6 85 0.8× 72 1.1× 31 0.8× 9 0.3× 7 0.4× 7 149
Ekaterine Alexandris United States 9 158 1.6× 148 2.2× 58 1.5× 26 1.0× 6 0.3× 16 226
Hwei-Chung Wang Taiwan 8 71 0.7× 33 0.5× 47 1.2× 41 1.6× 20 1.1× 15 138
A Murias Spain 6 86 0.9× 52 0.8× 13 0.3× 32 1.2× 5 0.3× 17 123
Agnès Ducoulombier France 6 113 1.1× 59 0.9× 15 0.4× 22 0.8× 6 0.3× 14 138
V. Labonia Italy 8 169 1.7× 47 0.7× 27 0.7× 126 4.8× 81 4.3× 16 246
B. Valenza France 6 67 0.7× 34 0.5× 9 0.2× 31 1.2× 4 0.2× 10 91
Carlotta Defferrari Italy 8 136 1.3× 150 2.2× 71 1.9× 38 1.5× 6 0.3× 23 235

Countries citing papers authored by A. Martoni

Since Specialization
Citations

This map shows the geographic impact of A. Martoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Martoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Martoni more than expected).

Fields of papers citing papers by A. Martoni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Martoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Martoni. The network helps show where A. Martoni may publish in the future.

Co-authorship network of co-authors of A. Martoni

This figure shows the co-authorship network connecting the top 25 collaborators of A. Martoni. A scholar is included among the top collaborators of A. Martoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Martoni. A. Martoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mutri, V., Carmine Pinto, S. Giaquinta, et al.. (2011). Phase I study of sorafenib and cisplatin/pemetrexed regimen in untreated malignant pleural mesothelioma (MPM) patients: Italian SoMe Study.. Journal of Clinical Oncology. 29(15_suppl). 7087–7087. 2 indexed citations
2.
James, R.D., Sandro Barni, Ludwig Fischer von Weikersthal, et al.. (2010). Improving chemotherapy capacity by switching from i.v. to oral vinorelbine. University of Southern Denmark Research Portal (University of Southern Denmark). 4. 14–18. 5 indexed citations
3.
Barni, Sandro, Vittorio Gebbia, Olfred Hansen, et al.. (2010). Improving chemotherapy capacity by switching from intravenous to oral vinorelbine: TAMINO, an international time and motion audit. Lung Cancer. 67. S4–S4. 4 indexed citations
4.
5.
6.
James, R.D., Sandro Barni, Vittorio Gebbia, et al.. (2009). 3612 Improving chemotherapy capacity by switching from intravenous to oral vinorelbine: TAMINO, an international time and motion audit. European Journal of Cancer Supplements. 7(2). 211–212. 2 indexed citations
7.
Scagliotti, Giorgio V., Andrea Rossi, Silvia Novello, et al.. (2004). Gefitinib (ZD1839) combined with gemcitabine or vinorelbine as single-agent in elderly patients with advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 22(14_suppl). 7081–7081. 25 indexed citations
8.
Martoni, A.. (2003). Breast cancer in the older woman. Critical Reviews in Oncology/Hematology. 46(3). 207–209. 1 indexed citations
9.
Angelelli, Bruna, et al.. (1999). Pilot study on induction chemotherapy with cisplatin, epirubicin, etoposide and bleomycin in cervical cancer stage Ib, IIa and IIb.. PubMed. 19(1B). 765–8. 1 indexed citations
10.
Martoni, A., et al.. (1997). Chemotherapy of advanced ovarian cancer.. PubMed. 2. g20–6. 1 indexed citations
11.
Martoni, A., et al.. (1995). CEA, MCA, CA 15.3 and CA 549 and their combinations in expressing and monitoring metastatic breast cancer: a prospective comparative study. European Journal of Cancer. 31(10). 1615–1621. 29 indexed citations
12.
Martoni, A., et al.. (1994). Combined Chemo-Immuno-Hormonotherapy of Advanced Renal Cell Carcinoma. Journal of Chemotherapy. 6(5). 349–353. 4 indexed citations
13.
Cuna, G. Robustelli della, F Pannuti, A. Martoni, et al.. (1994). Aminoglutethimide in advanced breast cancer: prospective, randomized comparison of two dose levels. Italian Cooperative Group.. PubMed. 13(6B). 2367–71. 8 indexed citations
14.
Busutti, L., M Mastrorilli, M Schiavina, et al.. (1994). Neoadjuvant chemotherapy for non small cell lung carcinoma-stage III A-B. Lung Cancer. 11. 186–186. 1 indexed citations
15.
Zamagni, C., et al.. (1991). 5-Fluorouracil, Epirubicin and Cyclophosphamide (FEC Combination) in Advanced Breast Cancer. Journal of Chemotherapy. 3(2). 126–129. 6 indexed citations
16.
Martoni, A., Barbara Melotti, M. Guaraldi, et al.. (1990). High-dose epiribicin for untreated patients with advanced tumours: a phase I study. European Journal of Cancer and Clinical Oncology. 26(11-12). 1137–1140. 16 indexed citations
17.
Pannuti, F, et al.. (1988). Adjuvant therapy for operable breast cancer with medroxyprogesterone acetate alone in postmenopausal patients or in combination with CMF in premenopausal patients. European Journal of Cancer and Clinical Oncology. 24(3). 423–429. 16 indexed citations
18.
Martoni, A., et al.. (1988). CA 15.3 and CEA Plasma Level Monitoring in Patients with Breast Cancer. The International Journal of Biological Markers. 3(3). 154–158. 8 indexed citations
19.
Martoni, A., et al.. (1985). The new anthracycline 4-demethoxydaunorubicin by oral route in advanced pretreated breast cancer and melanoma. A pilot study.. PubMed. 11(2). 127–31. 6 indexed citations
20.
Pannuti, F, Fiorenza Fruet, G. Lelli, et al.. (1981). Monochemotherapy (Adriamycin) for metastatic breast cancer in progression after sequential hormone-chemotherapy (MAP and CMF). Pilot study.. PubMed. 23(1). 25–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G Moro Breakdown of academic impact, for papers by Donatella Grasso Breakdown of academic impact, for papers by Robert McCroskey Breakdown of academic impact, for papers by Ekaterine Alexandris Breakdown of academic impact, for papers by Hwei-Chung Wang Breakdown of academic impact, for papers by A Murias Breakdown of academic impact, for papers by Agnès Ducoulombier Breakdown of academic impact, for papers by V. Labonia Breakdown of academic impact, for papers by B. Valenza Breakdown of academic impact, for papers by Carlotta Defferrari
Rankless by CCL
2026